Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
Close
  • Menu
  • Setting

Recombinant Human Thrombopoietin/TPO

Catalog No.
PH2022
Recombinant Human Thrombopoietin/TPO
Grouped product items
Size Price Stock Qty
10ug
Special Price $153.00 Regular Price $340.00
In stock
100ug
Special Price $513.00 Regular Price $1,140.00
In stock
For scientific research use only and should not be used for diagnostic or medical purposes.

Tel: +1-832-696-8203

Email: sales@apexbt.com

Worldwide Distributors

No Related Posts

Background

Thrombopoietin (Tpo), is a key regulator of megakaryocytopoiesis and thrombopoiesis. It is principally produced in the liver and is bound and internalized by the receptor Tpo R/c-mpl. Defects in the Tpo-Tpo R signaling pathway are associated with a variety of platelet disorders [1-3]. The 353 amino acid (aa) human Tpo precursor is cleaved to yield the 332 aa mature protein. Mature human Tpo shares approximately 70% aa sequence homology with mouse and rat Tpo. It is an 80-85 kDa protein that consists of an N-terminal domain with homology to Erythropoietin (Epo) and a C-terminal domain that contains multiple N-linked and O-linked glycosylation sites [4, 5]. Tissue specific alternate splicing of human Tpo generates multiple isoforms with internal deletions, insertions, and/or C-terminal substitutions [6]. Tpo promotes the differentiation, proliferation, and maturation of MK and their progenitors [4, 5, 7]. Several other cytokines can promote these functions as well but only in cooperation with Tpo [8, 9]. Notably, IL-3 independently induces MK development, although its effects are restricted to early in the MK lineage [8, 9]. Tpo additionally promotes platelet production, aggregation, ECM adhesion, and activation [10, 13]. It is cleaved by platelet-derived thrombin following Arg191 within the C-terminal domain and subsequently at other sites upon extended digestion [14]. Full length Tpo and shorter forms circulate in the plasma [4, 5]. The C-terminal domain is not required for binding to Tpo R or inducing MK growth and differentiation [5].

Reference

[1]. Deutsch, V.R. and A. Tomer (2006) Br. J. Haematol. 134:453.

[2]. Kaushansky, K. (2005) J. Clin. Invest. 115:3339.

[3]. Li, J. et al. (1999) Br. J. Haematol. 106:345.

[4]. Bartley, T.D. et al. (1994) Cell 77:1117.

[5]. de Sauvage, F.J. et al. (1994) Nature 369:533.

[6]. Marcucci, R. and M. Romano (2008) Biochim. Biophys. Acta 1782:427.

[7]. Kaushansky, K. et al. (1994) Nature 369:568.

[8]. Kaushansky, K. et al. (1995) Proc. Natl. Acad. Sci. 92:3234.

[9]. Broudy, V.C. et al. (1995), Blood 85:1719.

[10]. Lok, S.I. et al. (1994) Nature 369:565.

[11]. Chen, J. et al. (1995) Blood 86:4054.

[12]. Oda, A. et al. (1996) Blood 87:4664.

[13]. Van Os, E. et al. (2003) Br. J. Haematol. 121:482.

[14]. Kato, T. et al. (1997) Proc. Natl. Acad. Sci. 94:4669.

Description

Accession #

P40225

Alternate Names

Megakaryocyte colony-stimulating factor; MGDFC-mpl ligand; MKCSF; THPO; Thrombopoietin; Tpo

Source

Human embryonic kidney cell, HEK293-derived human Thrombopoietin/Tpo protein

Protein sequence

Ser22-Gly353

M.Wt

52.9 kDa

Appearance

Solution protein.

Stability & Storage

Avoid repeated freeze-thaw cycles. It is recommended that the protein be aliquoted for optimal storage. 12 months from date of receipt, -20 to -70 °C as supplied.

Concentration

0. 2 mg/mL

Formulation

Dissolved in sterile PBS buffer.

Reconstitution

We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. This solution can be diluted into other aqueous buffers.

Biological Activity

Measured in a cell proliferation assay using MO7e human megakaryocytic leukemic cells. The EC50 for this effect is 0.3-2 ng/mL.

Shipping Condition

Shipping with dry ice.

Handling

Centrifuge the vial prior to opening.

Usage

For Research Use Only! Not to be used in humans.

Quality Control

Quality Control & DataSheet

View current batch:
    Purity > 95%, determined by SDS-PAGE.
    Endotoxin: <0.010 EU per 1 ug of the protein by the LAL method.
  • Datasheet